Through continuous, active cost management, IMC reduced its annual G&A costs by 49% in 2023 and is now looking to significantly reduce its financial costs. TORONTO and GLIL YAM, Israel, May 29, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that in order to preserve its cash for to support accelerated growth in Germany it has closed a non-brokered priv ...

With Germany delivering accelerated growth after legalization, IMC is keeping all options open to maximize shareholder value TORONTO and GLIL YAM, Israel, May 28, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announces the termination of the preliminary term sheet signed on February 13, 2024 with Kadimastem Ltd a public company traded on the Tel Aviv Stock Exchange under the symbol (TASE:K ...

IM Cannabis Corp. [IMCC] Q1 2024 Earnings Conference Call May 8, 2024 9:00 AM ET Company Participants Oren Shuster - CEP Uri Birenberg - CFO Anna Taranko - IR Conference Call Participants Scott fortune - ROTH MKM Aaron Gray - Alliance Global Partners Operator Good morning, and welcome to IM Cannabis’ first quarter 2024 earnings conference call. Today's conference call is being recorded. At this time, I would like to turn the conference over to Anna Taranko, Director of Investor & Public Relation. Anna? Anna ...

IM Cannabis Corp. (IMCC) came out with a quarterly loss of $0.16 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.16 per share when it actually produced a loss of $0.18, delivering a surprise of -12.50%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.IM Cannabis, which belongs to the Z ...

IMC prepares for accelerated growth after legalization in Germany and recovers from the impact of the Israel-Hamas war. TORONTO and GLIL YAM, Israel, May 8, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2023, unless otherwise stated. Q1 2024 Financial ...

IM Cannabis (NASDAQ:IMCC) stock is rocketing higher on Wednesday following news that President Joe Biden’s Administration plans to reclassify marijuana.According to insider sources, the Biden Administration is planning to reclassify marijuana from a Schedule I drug to a Schedule III drug. With this rescheduling, cannabis would be in the same group as Tylenol with codeine, steroids and other Class I drugs.The rescheduling would also lower the restrictions on marijuana and allow for more research into its med ...

IM Cannabis Corp. (NASDAQ:IMCC) Q4 2023 Earnings Conference Call March 28, 2024 9:00 AM ET Company Participants Anna Taranko - Director, Investor & Public Relations Oren Shuster - Chief Executive Officer Uri Birenberg - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Operator Good morning and welcome to IM Cannabis' Fourth Quarter 2023 and Full Year 2023 Earnings Conference Call. Today's conference call is being recorded. At this time, I would like to turn the conference ov ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR Commission file number: 001-40065 IM Cannabis Corp. (Exact name of Registrant as specified in its charter) British Columbia, Canada (Jurisdiction of incorporation or organization) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION R ...

IM Cannabis Corp. (NASDAQ:IMCC) Q3 2023 Results Conference Call November 13, 2023 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executive Officer Itay Vago - Chief Financial Officer Conference Call Participants Scott Fortune - ROTH MKM Aaron Grey - Alliance Global Operator Good morning. And welcome to IM Cannabis' Third Quarter 2023 Earnings Conference Call. Today's conference call is being recorded. At this time, I would like to turn the conf ...

Exhibit 99.2 NOTICE TO READER The accompanying unaudited condensed interim consolidated financial statements of IM Cannabis Corp. (the “Company”) have been prepared by and are the responsibility of management. The unaudited condensed interim consolidated financial statements have not been reviewed by the Company's auditors. F - 2 IM CANNABIS CORP. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2023 CANADIAN DOLLARS IN THOUSANDS (Unaudited) INDEX Page Interim Con ...